Clinical trial
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
NCT00185796 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00185796 |
|---|---|
| Title | TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD |
| Official title | Total Lymphoid Irradiation and Anti-Thymocyte Globulin as Conditioning for Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for the Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML) |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloproliferative Disorders, Blood Cancer, Myelodysplastic Syndromes |
| Intervention type | Procedure |
| Interventions | Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as Conditioning (ATG) |
| Enrollment | 77 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2014 |
| Completion | Feb 1, 2015 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: